MAP2K7 and neoplasm: Several mechanisms were proposed for tumour-BRAFi resistance, including the reactivation of downstream kinases in the MAPK cascade, for instance, MEK or ERK, as well as the activation of the PI3K/mTOR pathway, also involved in cell survival and proliferation (Knispel et al., 2018).